---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-020701"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2021-08-19T23:59:59+00:00"
generated_at: "2026-06-29T08:54:50.762608+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MariMed Q2 revenue $32.6M (+239% YoY); raises FY2021 guidance to $118M revenue, $32M EBITDA

## Summary
- Revenue $32.6M, up 239% YoY and 32% QoQ; net income $7.6M vs loss $1.1M in Q2 2020.
- EBITDA $12.3M (+440% YoY); Adjusted EBITDA $13.9M (43% margin).
- Raises FY2021 guidance: revenue to $118M (from $100M), EBITDA to $32M (from $30M); first-time Adj. EBITDA guide of $42M.
- Positive operating cash flow $10.8M; working capital $20.9M, up $7.2M from Q1.
- Growth driven by wholesale in MA, retail in MA/IL, and branded product licensing in six states.

## SEC filing metadata
- accession: 0001493152-21-020701
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2021-08-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000149315221020701/0001493152-21-020701-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000149315221020701/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-020701
- JSON: https://secwatch.observer/filing/0001493152-21-020701.json
- Plain text: https://secwatch.observer/filing/0001493152-21-020701.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.